Rein Therapeutics, Inc.
RNTX · XNASCIK 1420565fmd_028QB8W3FAS4H8B6EQ1BDKW7WJManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2015 to Jun 30, 2026, 43 periods
Proof
Every number on this company page links to a proof: the filing it came from, the XBRL tag, the knowledge interval, and the raw facts it was built from. Hover any cell in Financials for the summary; click to open the full record.
How to read a proof
- Accession and form identify the filing; the SEC link opens the primary document.
- Tag, dimensions and decimals identify the fact within that filing.
- The knowledge interval says when this value became known and, if restated, when it stopped being current.
- Derived values list every as-reported fact in the chain.